Loading...
XNAS
NAKA
Market cap3mUSD
Dec 05, Last price  
0.51USD
1D
-7.39%
1Q
-87.49%
IPO
-80.82%
Name

Kindly MD Inc

Chart & Performance

D1W1MN
XNAS:NAKA chart
P/E
P/S
1.13
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
3m
-27.83%
2,504,3193,787,0773,768,5982,719,840
Net income
-4m
L+123.66%
149,336-2,540,593-1,617,461-3,617,647
CFO
-3m
L+583.86%
121,441-140,383-449,489-3,073,891

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
IPO date
May 31, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2024‑122023‑122022‑122021‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT